https://doi.org/10.4081/ecj.2024.12815

Comparison of high flow and standard oxygen therapy in patients with acute hypoxemic respiratory failure in emergency department. A randomized controlled cross over superiority trial

Vol. 20 No. 4 (2024)
Submitted: 16 July 2024
Accepted: 9 August 2024
Published: 11 September 2024
High flow nasal cannula, acute hypoxemic respiratory failure
Abstract Views: 3613
PDF: 337
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Mamidi Rahul Rohan
Department of Emergency Medicine, Nizam’s Institute of Medical Sciences, Hyderabad, India.
Ashima Sharma
https://orcid.org/0000-0001-9646-9695
Department of Emergency Medicine, Nizam’s Institute of Medical Sciences, Hyderabad, India.
Mohammed Ismail Nizami
ismailnizami83@gmail.com
Department of Emergency Medicine, Nizam’s Institute of Medical Sciences, Hyderabad, India.
Lubna Tarannum
Consultant Emergency Physician, Kamineni Hospital, Hyderabad, India.

The aim of our study was to determine whether high flow oxygen therapy reduced the rate of endotracheal intubation and improve pulmonary outcome score. A total of 300 consecutive patients were enrolled in the study. The etiologies of acute respiratory failure were classified into trauma, lung diseases, fluid overload states and undifferentiated. Patients were randomized by block randomization method into two groups. First group received HFNC while the second received conventional oxygen therapy. Patients in both the groups were escalated to either NIV or invasive mechanical ventilator support if there were any signs of respiratory distress noted. Pulmonary outcome scoring done at 2 hours was designed to see if there was any improvement in patient’s condition in both the groups. SPSS (version 21.0, Illinois, Chicago) was used for the statistical analysis. The partial pressures of oxygen improved significantly in the HFNC group as compared to the COT group irrespective of the etiology. The partial pressures of CO2 on ABG were similar in both the groups until 12 hrs. However, pCO2 was earlier reduced in the HFNC group as compared to the COT group. Steady decrease in serum lactate levels were observed in HFNC group. The base deficit was corrected between 6-12 hours in patients of HFNC group which could not be seen in patients of COT group. There was a statistically significant difference noted at 12 and 24 hours between the two groups. The mean length of stay in HFNC group was around 4 days which was less compared to the length of hospital stay in COT which was an average of 7 days. The mortality in HFNC group was 4% and in COT group was 7.33% in our study. The study demonstrated that the use of HFNC in ED patients presenting with AHRF was associated with a greater reduction in need for escalation of ventilation requirements and improves pulmonary outcomes compared with standard oxygen therapy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Pandor A, Thokala P, Goodacre S, et al. Pre-hospital non- invasive ventilation for acute respiratory failure: A systematic review and cost- effectiveness evaluation. Health Technol Assess (Rockv) 2015;19:1–8. DOI: https://doi.org/10.3310/hta19420
Vignaux L, Vargas F, Roeseler J, et al. Patient-ventilator asynchrony during non-invasive ventilation for acute respiratory failure: A multicenter study. Intensive Care Med 2009;35:840–6. DOI: https://doi.org/10.1007/s00134-009-1416-5
Nishimura M. Highflow nasal cannula oxygen therapy in adults: Physiological benefits, indication, clinical benefits, and adverse effects. Respir Care 2016;61:529-41. DOI: https://doi.org/10.4187/respcare.04577
Sotello D, Rivas M, Mulkey Z, Nugent K. Highflow nasal cannula oxygen in adult patients: A narrative review. Am J Med Sci 2015;349:179-85. DOI: https://doi.org/10.1097/MAJ.0000000000000345
Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated humidified high-flow nasal oxygen in adults: Mechanisms of action and clinical implications. Chest 2015;148:253-61. DOI: https://doi.org/10.1378/chest.14-2871
Cuquemelle E, Pham T, Papon JF, et al. Heated and humidified high‑flow oxygen therapy reduces discomfort during hypoxemic respiratory failure. Respir Care 2012;57:1571-7 DOI: https://doi.org/10.4187/respcare.01681
Parke R, McGuinness S, Eccleston M. Nasal highflow therapy delivers low level positive airway pressure. Br J Anaesth 2009;103:886-90. DOI: https://doi.org/10.1093/bja/aep280
Sztrymf B, Messika J, Bertrand F, et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: A prospective pilot study. Intensive Care Med 2011;37:1780-6. DOI: https://doi.org/10.1007/s00134-011-2354-6
Kernick J, Magarey J. What is the evidence for the use of high flow nasal cannula oxygen in adult patients admitted to critical care units? A systematic review. Australian Critical Care 2010;23:53–70. DOI: https://doi.org/10.1016/j.aucc.2010.01.001
Dubey A, Sharma P. Profile of respiratory problems in patients attending a tertiary care center OPD - A study from central India. Int J Med Res Rev 2015;3:743-7. DOI: https://doi.org/10.17511/ijmrr.2015.i7.142
Kerai S, Singh R, Saxena KN, et al. A Retrospective Study on Experience of High-flow Nasal Cannula Oxygen in Critically Ill COVID-19 Adult Patients Admitted to Intensive Care Unit. Indian J Crit Care Med 2022;26:62-6. DOI: https://doi.org/10.5005/jp-journals-10071-24097
Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372:2185–96. DOI: https://doi.org/10.1056/NEJMoa1503326
Vikas Marwah, P.S. Shafin Babu, C.D.S. Katoch, et al. Effectiveness of high flow nasal cannula oxygen therapy in patients of acute pulmonary thromboembolism with acute hypoxemic respiratory failure. MJAFI 2022;78:448-53. DOI: https://doi.org/10.1016/j.mjafi.2021.03.014
Rali AS, Garies T, Narendra D, et al. High-flow nasal cannula: COVID 19 and beyond. Indian J Respir Care 2020;9:134-40. DOI: https://doi.org/10.4103/ijrc.ijrc_47_20
Sadasivam K, Ramachandran B. A Survey of Humidified High-flow Nasal Cannula Usage in Indian Pediatric Intensive Care Units. Indian J Crit Care Med 2020;24:996-8. DOI: https://doi.org/10.5005/jp-journals-10071-23628
Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195:1207–15. DOI: https://doi.org/10.1164/rccm.201605-0916OC
Riera J, Pérez P, Cortés J, et al. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: A cohort study using electrical impedance tomography. Respir Care 2013;58:589–96. DOI: https://doi.org/10.4187/respcare.02086
Jones PG, Kamona S, Doran O, et al. Randomized controlled trial of humidified high-flow nasal oxygen for acute respiratory distress in the emergency department: The HOT-ER study. Respir Care 2016;61:291–9. DOI: https://doi.org/10.4187/respcare.04252
Zhu Y, Yin H, Zhang R, Wei J. High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients with acute respiratory failure: A systematic review and meta-analysis of randomized controlled trials. BMC Pulm Med 2017;17:201. DOI: https://doi.org/10.1186/s12890-017-0525-0
Roca O, Riera J, Torres F et al. High-flow oxygen therapy in acute respiratory failure. Respi Care 2010;55:408-13.
Bell N, Hutchinson CL, Green TC, et al. Randomised control trial of humidified high flow nasal cannulae versus standard oxygen in the emergency department. Emerg Med Australas 2015;27:537–41. DOI: https://doi.org/10.1111/1742-6723.12490
Zhang J, Lin L, Pan K, et al. High-flow nasal cannula therapy for adult patients. J Int Med Res 2016;44:1200–11. DOI: https://doi.org/10.1177/0300060516664621
Messika J, Goutorbe P, Hajage D, Ricard JD. Severe pulmonary embolism managed with high-flow nasal cannula oxygen therapy. Eur J Emerg Med 2017;24:230–2. DOI: https://doi.org/10.1097/MEJ.0000000000000420
Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care 2016;35:200–5. DOI: https://doi.org/10.1016/j.jcrc.2016.05.022
Papazian L, Corley A, Hess D, et al. Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med 2016;42:1336–49. DOI: https://doi.org/10.1007/s00134-016-4277-8

How to Cite

Rahul Rohan, M., Sharma, A., Nizami, M. I., & Tarannum, L. (2024). Comparison of high flow and standard oxygen therapy in patients with acute hypoxemic respiratory failure in emergency department. A randomized controlled cross over superiority trial. Emergency Care Journal, 20(4). https://doi.org/10.4081/ecj.2024.12815
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.